‘Nowhere to hide’: As biotech stocks plummet, an industry is being reshaped by the fallout By Adam Feuerstein, Damian Garde, and Matthew HErper Mike Reddy for STAT Biotech investors, once the envy of Wall Street, have slipped into despondency. After a double-digit decline in 2021, the sector has fallen another 20% in the new year, erasing billions in value and leading even the most seasoned investors to question whether biotech has further to fall. Read More |
No comments